Type(s) of Cancer
Lung
Lung
Study Phase
Phase 3
Study Completion Date
December 2019
December 2019
NCT02785952Uploaded 03-25-2023
Access via NCI by Request
PDS UID: nci-data-510
A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-Map Sub-Study)
Files: NCT02785952-D1



Data DictionaryNCT02785952-D1-Data-Dictionary_3.pdf

DATANCT02785952-D1-Dataset_4.csv

OTHERREADME.pdf
Files: NCT02785952-D2



Data DictionaryNCT02785952-D2-Data-Dictionary_2.pdf

DATANCT02785952-D2-Dataset_3.csv

OTHERREADME.pdf
Files: NCT02785952-D3



Data DictionaryNCT02785952-D3-Data-Dictionary_1.pdf

DATANCT02785952-D3-Dataset_1.csv

OTHERREADME.pdf